A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Fernando G. Zampieri(University of Alberta), Samantha Bates(Wellesley College), Helen Young(Austin Hospital), Emma Saylor(Alberta Health Services), Krista Wetzig(Alberta Health Services), Peter Krüger(Princess Alexandra Hospital), Michael Joannidis(Innsbruck Medical University), Paul M. Palevsky(VA Pittsburgh Healthcare System), Haibo Qiu(Zhongda Hospital Southeast University), Matthew A. Weir(Western University), John Mulder(Alberta Health Services), Craig French(The University of Melbourne), Sean M. Bagshaw(Alberta Health Services), François Lamontagne(Université de Sherbrooke), Gordon Laurie(Alberta Health Services), Daniel F. McAuley(Queen's University Belfast), Antoine Schneider(Centre Hospitalier Universitaire Vaudois), Gerard Fennessy(Austin Hospital), Bram Rochwerg(Impact), Glenn M. Eastwood(Austin Hospital), Jason Meyer(Alberta Health Services), Shay McGuinness, Kathleen D. Liu(University of California San Francisco Medical Center), Bruno R. da Costa(University of Oxford), Marlies Ostermann(St Thomas' Hospital), Sathyajith Koottayi(Alberta Health Services), Bin Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Ron Wald(St. Michael's Hospital), Stèphane Gaudry(Inserm), Forbes McGain(Western Health), Ellen Venz(Alberta Health Services), Leah Peck, Orla M. Smith(University of Helsinki), Suvi T. Vaara(University of Helsinki), Didier Dreyfuss(Inserm), Ville Pettilä(University of Helsinki)

Critical Care

August 25, 2022

Cited by 19

Related Papers

|Intensive Care Medicine|2017|6.8k

|Intensive Care Medicine|2021|5.1k

|Critical Care Medicine|2017|3.8k

|Critical Care Medicine|2021|2.8k

|The Lancet Infectious Diseases|2020|1.8k